Literature DB >> 29200151

Recurrent Acute Chest Syndrome in Pediatric Sickle Cell Disease: Clinical Features and Risk Factors.

Gaylen D Patterson1, Hafsat Mashegu2, Jordan Rutherford1, Samantha Seals3, David Josey4, Cynthia Karlson2, Melissa McNaull2, Warren May1, Clinton Carroll1, Frederick E Barr5, Suvankar Majumdar2.   

Abstract

Acute chest syndrome (ACS) is a common and serious lung complication in sickle cell disease. A retrospective medical chart review was performed over a 6-year period in all pediatric ACS patients to investigate whether factors during the initial hospitalization were associated with recurrent ACS episodes. There were 386 episodes of ACS: 149 had only 1 episode of ACS, and 76 had >1 episode of ACS; 172 (76.4%) had hemoglobin SS, and 39 (17.3%) had hemoglobin SC. The most common presenting features were fever (83%), pain (70%), and cough (61%), which changed with the number of ACS episodes. Children <4 years old were at greatest risk of recurrent ACS (P=0.018). In addition, history of asthma (adjusted incident rate ratio [IRR]=1.52; 95% confidence interval [CI], 1.22-1.98; P<0.0001), shortness of breath (IRR, 1.29; 95% CI, 1.02-1.62; P=0.033), and length of hospital stay (IRR, 1.04; 95% CI, 1.01-1.08; P=0.017) were significantly associated with prospective ACS events. Multiple episodes of ACS are common in sickle cell disease, and certain risk factors during the initial hospitalization are associated with recurrent ACS.

Entities:  

Mesh:

Year:  2018        PMID: 29200151     DOI: 10.1097/MPH.0000000000001012

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Predictors of Recurrent Acute Chest Syndrome in Pediatric Sickle Cell Disease: A Retrospective Case-Control Study.

Authors:  Abdullah A Yousef; Hwazen A Shash; Ali N Almajid; Ammar A Binammar; Hamza Ali Almusabeh; Hassan M Alshaqaq; Mohammad H Al-Qahtani; Waleed H Albuali
Journal:  Children (Basel)       Date:  2022-06-15

Review 2.  A Comprehensive Review of the Treatment and Management of Pain in Sickle Cell Disease.

Authors:  Jacob Fiocchi; Ivan Urits; Vwaire Orhurhu; Mariam Salisu Orhurhu; Stephen Giacomazzi; Briggs Hoyt; Alan D Kaye; Rachel J Kaye; Omar Viswanath
Journal:  Curr Pain Headache Rep       Date:  2020-03-21

3.  Inhaled corticosteroid use to prevent severe vaso-occlusive episode recurrence in children between 1 and 4 years of age with sickle cell disease: a multicenter feasibility trial.

Authors:  Leah Vance Utset; Zalaya Ivy; Shaina M Willen; Mark Rodeghier; Amanda Watt; Leann Schilling; Chantel L Jenkins; Stefanie Pepper; Barbara Speller-Brown; Deepika S Darbari; Suvankar Majumdar; Olufolake Adisa; Michael R DeBaun
Journal:  Am J Hematol       Date:  2018-02-05       Impact factor: 10.047

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.